BioNTech Correlations

BNTX Stock

USD 106.99 1.12 1.06%

The current 90-days correlation between BioNTech SE and Incyte is 0.29 (i.e., Modest diversification). The correlation of BioNTech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

BioNTech Correlation With Market

Very weak diversification

The correlation between BioNTech SE and DJI is 0.45 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding BioNTech SE and DJI in the same portfolio, assuming nothing else is changed.

Build AI portfolio with BioNTech Stock

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioNTech SE. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

Moving together with BioNTech Stock

0.68	GXEA	Galapagos NV Earnings Call This Week	Pair Corr
0.73	8VP1	AVRICORE HEALTH INC	Pair Corr
0.74	CMB	Cambium Bio	Pair Corr
0.7	VALN	Valneva SE ADR	Pair Corr
0.64	DNLI	Denali Therapeutics	Pair Corr
0.64	DNTH	Dianthus Therapeutics	Pair Corr
0.75	6C1	CytomX Therapeutics	Pair Corr
0.75	AVH	Avita Medical	Pair Corr
0.63	DRTS	Alpha Tau Medical	Pair Corr
0.65	DVAX	Dynavax Technologies Earnings Call This Week	Pair Corr

Moving against BioNTech Stock

0.55	CDIOW	Cardio Diagnostics	Pair Corr
0.46	VCYT	Veracyte	Pair Corr
0.39	DXB	Dimerix Earnings Call This Week	Pair Corr
0.75	XE9	Xencor Inc	Pair Corr
0.64	DWTX	Dogwood Therapeutics	Pair Corr
0.62	BIM	Biomerieux SA	Pair Corr
0.6	VSTM	Verastem	Pair Corr
0.54	VRAX	Virax Biolabs Group	Pair Corr
0.48	DYAI	Dyadic International	Pair Corr
0.45	VKTX	Viking Therapeutics	Pair Corr
0.4	KTTAW	Pasithea Therapeutics	Pair Corr

Related Correlations Analysis

	INCY	GMAB	UTHR	TEVA	DXCM	NTRA	PHG	STE	RPRX	BIIB
INCY		0.13	-0.32	-0.08	-0.09	-0.07	0.44	0.39	0.26	0.03	INCY
GMAB	0.13		0.3	0.48	0.67	0.7	0.07	0.34	-0.06	0.07	GMAB
UTHR	-0.32	0.3		0.18	0.11	0.34	-0.54	-0.31	-0.24	0.23	UTHR
TEVA	-0.08	0.48	0.18		0.88	0.08	0.47	-0.34	0.64	0.54	TEVA
DXCM	-0.09	0.67	0.11	0.88		0.4	0.35	-0.08	0.42	0.4	DXCM
NTRA	-0.07	0.7	0.34	0.08	0.4		-0.26	0.42	-0.4	0.0	NTRA
PHG	0.44	0.07	-0.54	0.47	0.35	-0.26		-0.06	0.76	0.36	PHG
STE	0.39	0.34	-0.31	-0.34	-0.08	0.42	-0.06		-0.35	-0.43	STE
RPRX	0.26	-0.06	-0.24	0.64	0.42	-0.4	0.76	-0.35		0.71	RPRX
BIIB	0.03	0.07	0.23	0.54	0.4	0.0	0.36	-0.43	0.71		BIIB
	INCY	GMAB	UTHR	TEVA	DXCM	NTRA	PHG	STE	RPRX	BIIB

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

DXCM	+ 0.88	TEVA
RPRX	+ 0.76	PHG
BIIB	+ 0.71	RPRX
NTRA	+ 0.7	GMAB
DXCM	+ 0.67	GMAB
RPRX	+ 0.64	TEVA

High negative correlations

PHG	- 0.54	UTHR
BIIB	- 0.43	STE
RPRX	- 0.4	NTRA
RPRX	- 0.35	STE
STE	- 0.34	TEVA
UTHR	- 0.32	INCY

Risk-Adjusted Indicators

There is a big difference between BioNTech Stock performing well and BioNTech Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze BioNTech's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
INCY	1.63	(0.12)	0.00	(0.05)	0.00	0.00	4.10	(3.38)	13.76
GMAB	1.78	0.00	0.00	0.06	2.17	(1.86)	4.09	(3.42)	9.44
UTHR	0.96	0.04	0.00	0.19	1.16	(0.92)	1.94	(1.99)	5.21
TEVA	1.33	0.46	0.36	0.60	0.82	(1.65)	3.59	(1.61)	8.88
DXCM	1.47	0.33	0.18	0.46	1.29	(1.59)	3.31	(2.78)	10.50
NTRA	1.65	(0.02)	(0.02)	0.03	2.59	(1.68)	3.69	(4.15)	14.46
PHG	1.35	0.09	0.06	0.13	1.69	(1.34)	2.53	(2.41)	13.66
STE	1.03	(0.15)	0.00	(0.08)	0.00	0.00	1.79	(2.68)	10.43
RPRX	0.91	0.21	0.15	0.59	0.94	(1.01)	2.01	(1.50)	5.25
BIIB	1.54	0.31	0.15	0.40	1.72	(1.69)	4.38	(2.84)	12.20

BioNTech Corporate Management

Katalin Kariko	Senior Therapies	Profile
Jens Holstein	CFO Board	Profile
Annemarie Hanekamp	Chief Board	Profile
Sylke Maas	Vice Strategy	Profile
Douglas Maffei	Vice Relations	Profile
Michael Boehler	MD Communications	Profile
Siegbert Kloos	Datand Digital	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC